Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Varicella vaccine].

P Bégué1

  • 1Hôpital d'enfants Armand-Trousseau, Paris, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|October 16, 1999
PubMed
Summary

The varicella vaccine is highly effective in healthy and immunocompromised children, offering significant benefits. Widespread vaccination is cost-effective, reducing parental work absence due to childhood varicella illness.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Medecine et maladies infectieuses·2024
Same author

[Varicella and zoster vaccines].

Virologie (Montrouge, France)·2021
Same author

Journal de pediatrie et de puericulture·2020
Same author

[Immunization schedule 2013].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2013
Same author

[The future of vaccination in France].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2013
Same author

Bulletin InfoVac-France.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2012

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Context:

  • Varicella (chickenpox) poses risks to both healthy and immunocompromised children.
  • Extensive research on varicella vaccine efficacy has been conducted globally since 1974.
  • Vaccination guidelines exist for specific populations, including healthcare professionals.

Purpose:

  • To evaluate the efficacy of the varicella vaccine in diverse pediatric populations.
  • To assess the public health and economic benefits of widespread varicella vaccination.
  • To inform vaccination recommendations for at-risk individuals.

Summary:

  • The varicella vaccine demonstrates high efficacy (around 94%) in healthy children.
  • It is also effective in immunocompromised children, requiring administration during chemotherapy pauses.
  • Benefits and cost analyses indicate that generalized childhood varicella vaccination is advantageous, offsetting costs associated with parental work leave.

Impact:

  • Supports the recommendation of varicella vaccination for broader pediatric and adult populations.
  • Highlights the economic advantages of preventing varicella through vaccination.
  • Contributes to public health strategies for infectious disease control.

Related Experiment Videos